SLAM Bio
Oncology Biotech developing first-in-class antibodies, ADCs and bispecifics to conquer life-threatening cancers and unmet needs including AML, MDS, CTCL and FL. Entering the clinic in 2026.
)
January 11-14, 2027 | San Francisco
January 11-14, 2027 | San Francisco
)
)
January 11-14, 2027 | San Francisco
){kind=logo}
)